Is pharmacogenomic testing ready for prime time?

Pharmacogenomic Testing and Antithrombotic Therapy: Ready for Prime Time?

Pharmacogenomics is the study of an individual's interaction with a specific drug based upon the genetic make-up of the individual. Pharmacogenomic testing can be a powerful tool in testing a drug's potential efficacy and toxicity on an individual patient. For this tool to be used correctly, certain criteria have to be met. First and foremost is the strength of association between the genetic v...

Is sperm DNA fragmentation testing ready for prime time?

vertical gastric plication: is it ready for prime-time?

FGF23: is it ready for prime time?

Since the identification of fibroblast growth factor 23 (FGF23) more than a decade ago, interest in this hormone has grown dramatically among both nephrologists and endocrinologists. FGF23, initially identified in patients with rare forms of hypophosphatemia, is also increased in patients with chronic kidney disease (CKD). A handful of studies have suggested that increased circulating concentra...

Ginger: is it ready for prime time?

On the basis of substantial preclinical data showing the preventive efficacy of ginger and its constituents in vitro and in animal models, as well as a phase I pilot trial indicating that ginger extract is well tolerated in humans, Citronberg and colleagues conducted a pilot trial of ginger extract (2 g/day for 28 days) on biomarkers of cell proliferation [human telomerase reverse transcriptase...